BVCF Raising $400 Million for China Life Science Fund

BVCF (BioVeda China Fund), a Shanghai-based life science fund focused on private equity and venture investment, is raising money for a fourth US dollar fund, targeting $400 million. That is twice the size of BVCF's third fund, which closed in 2014, and it equals BVCF's current total of funds under management. The company expects its first close in a few months and the final close before the end of 2016, according to an unnamed source who spoke to China Money Network. More details.... Share this with colleagues: // //